The effect of ivabradine on hospitalization of heart failure patients: A retrospective cohort study
Background: Ivabradine is recommended in heart failure (HF) patients to reduce cardiovascular death and hospitalization due to worsening of HF symptoms. Aims and Objectives: To study the effect of Ivabradine in addition to guideline-directed medical therapy (GDMT) in a group of HF patients with HR m...
Main Authors: | Sara Al-Balushi, Mohammed Fasihul Alam, Abdul Rehman Abid, Amal Sharfi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2021-01-01
|
Series: | Heart Views |
Subjects: | |
Online Access: | http://www.heartviews.org/article.asp?issn=1995-705X;year=2021;volume=22;issue=3;spage=165;epage=173;aulast=Al-Balushi |
Similar Items
-
Ivabradine in Chronic Heart Failure
by: Hadeer Eid, et al.
Published: (2020-06-01) -
Efficacy and safety evaluation of ivabradine in patients with non-ischemic heart failure
by: LIU Ying-xian, SONG Yan-jun, CHEN Wei, LIN Xue, LAI Jin-zhi, LI Jing-yi, WU Wei
Published: (2021-11-01) -
Ivabradine in heart failure patients with reduced ejection fraction and history of paroxysmal atrial fibrillation
by: Yu‐Sheng Lin, et al.
Published: (2022-08-01) -
Ivabradine therapy and correction of the target organ pathology in patients with ischemic chronic heart failure
by: M. V. Surovtseva, et al.
Published: (2013-06-01) -
Evaluation of ivabradine in left ventricular dyssynchrony and reverse remodeling in patients with chronic heart failure
by: Korhan Soylu, et al.
Published: (2020-08-01)